Brett's passion is taking nanoelectronic technology out of the theoretical realm to create practical products. His scientific vision led to him founding and serving as CTO of Cardea, a company building the access ports for the Internet of Biology via graphene biosensors. Brett is one of the few people in the world with the combined expertise in biology and nanotechnology needed to develop graphene as a viable bio-electronic device. He was a lead researcher on landmark field effect biosensing papers in Science, Nature Nanotechnology, Scientific Reports, and Nature Biotechnology. His early work established coupling of biochemical systems to carbon nanotubes, for which he won the Nottingham Prize from the Physical Electronics Conference. Dr. Goldsmith earned his PhD in Chemical and Material Physics at UCI, had a postdoc fellowship at University of Pennsylvania, helped develop research programs for ONR and DARPA, and has led the technical team for the world's leading nanotechnology company.